Table 2. Angiographical and procedural characteristics.
| Characteristics | Control group (n = 20) | Liraglutide group (n = 21) | p value |
|---|---|---|---|
| Number of disease vessels, n (%) | |||
| Single vessel disease | 4 (20%) | 3 (15%) | 0.94 |
| Double vessel disease | 10 (50%) | 10 (47%) | 0.88 |
| Triple vessel disease | 6 (30%) | 8 (38%) | 0.58 |
| Culprit lesion, n (%) | |||
| LAD | 10 (50%) | 12 (57%) | 0.65 |
| RCA | 5 (25%) | 4 (19%) | 0.93 |
| LCX | 5 (25%) | 5 (24%) | 0.78 |
| PCI | 17 (85%) | 19 (90%) | 0.95 |
| No. of stent per patients | 1.7 ± 1.3 | 1.5 ± 1.4 | 0.64 |
| CABG, n (%) | 1 (5%) | 1 (5%) | 0.77 |
Data are presented as mean value ± standard deviation or number or percentage (%) of patients. LAD, left anterior descending artery; RCA, right coronary artery; LCX, left circumflex artery; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.